IMCR
Price
$34.59
Change
+$0.51 (+1.50%)
Updated
Sep 26, 01:07 PM (EDT)
Capitalization
1.72B
40 days until earnings call
NRIX
Price
$8.92
Change
+$0.59 (+7.08%)
Updated
Sep 26, 03:46 PM (EDT)
Capitalization
636.82M
13 days until earnings call
Interact to see
Advertisement

IMCR vs NRIX

Header iconIMCR vs NRIX Comparison
Open Charts IMCR vs NRIXBanner chart's image
Immunocore Holdings
Price$34.59
Change+$0.51 (+1.50%)
Volume$749
Capitalization1.72B
Nurix Therapeutics
Price$8.92
Change+$0.59 (+7.08%)
Volume$400
Capitalization636.82M
IMCR vs NRIX Comparison Chart in %
Loading...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMCR vs. NRIX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMCR is a StrongBuy and NRIX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (IMCR: $34.08 vs. NRIX: $8.33)
Brand notoriety: IMCR and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMCR: 118% vs. NRIX: 135%
Market capitalization -- IMCR: $1.72B vs. NRIX: $636.82M
IMCR [@Biotechnology] is valued at $1.72B. NRIX’s [@Biotechnology] market capitalization is $636.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMCR’s FA Score shows that 0 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • IMCR’s FA Score: 0 green, 5 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, IMCR is a better buy in the long-term than NRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMCR’s TA Score shows that 5 TA indicator(s) are bullish while NRIX’s TA Score has 5 bullish TA indicator(s).

  • IMCR’s TA Score: 5 bullish, 5 bearish.
  • NRIX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than IMCR.

Price Growth

IMCR (@Biotechnology) experienced а +1.99% price change this week, while NRIX (@Biotechnology) price change was -7.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +9.02%, and the average quarterly price growth was +51.46%.

Reported Earning Dates

IMCR is expected to report earnings on Nov 05, 2025.

NRIX is expected to report earnings on Oct 09, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMCR($1.72B) has a higher market cap than NRIX($637M). IMCR YTD gains are higher at: 15.525 vs. NRIX (-55.786). IMCR has higher annual earnings (EBITDA): -1.31M vs. NRIX (-212.78M). IMCR has more cash in the bank: 883M vs. NRIX (486M). NRIX has less debt than IMCR: NRIX (51.9M) vs IMCR (436M). IMCR has higher revenues than NRIX: IMCR (356M) vs NRIX (88.4M).
IMCRNRIXIMCR / NRIX
Capitalization1.72B637M270%
EBITDA-1.31M-212.78M1%
Gain YTD15.525-55.786-28%
P/E RatioN/AN/A-
Revenue356M88.4M403%
Total Cash883M486M182%
Total Debt436M51.9M840%
TECHNICAL ANALYSIS
Technical Analysis
IMCRNRIX
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTAX31.60N/A
N/A
Fidelity Advisor Biotechnology A
FSPHX26.65N/A
N/A
Fidelity Select Health Care
GLCGX35.08N/A
N/A
Goldman Sachs Large Cap Gr Insghts A
NSOIX18.03N/A
N/A
North Star Opportunity I
ADGGX26.34N/A
N/A
American Century Disciplined Growth R5

IMCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMCR has been loosely correlated with NUVL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if IMCR jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCR
1D Price
Change %
IMCR100%
-0.55%
NUVL - IMCR
51%
Loosely correlated
-2.54%
NRIX - IMCR
51%
Loosely correlated
-4.25%
IMVT - IMCR
46%
Loosely correlated
+1.36%
IDYA - IMCR
46%
Loosely correlated
+0.08%
ROIV - IMCR
46%
Loosely correlated
+1.77%
More